Activated prothrombin complex concentrates and recombinant factor VIIa in the bleeding patient: are they appropriate and safe?
Aledort
Louis M
LM
D001779:Blood Coagulation Factors / Q000009:adverse effects* / Q000627:therapeutic use; D005167:Factor VII / Q000009:adverse effects* / Q000627:therapeutic use; D015942:Factor VIIa; D006470:Hemorrhage / Q000628:therapy*; D006801:Humans; D011994:Recombinant Proteins / Q000009:adverse effects* / Q000627:therapeutic use; D013927:Thrombosis / Q000209:etiology*
D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; C025667:prothrombin complex concentrates; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa